Understanding FAM210B's involvement in HCC could unveil novel insights into the disease's molecular underpinnings, potentially leading to the identification of new therapeutic targets and biomarkers for personalized treatment strategies. The gene discussed is MIMS2; the disease is hepatocellular carcinoma.